Related Experiment Video
Updated: Mar 31, 2026

Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach
Published on: October 18, 2024
Sleep disorders in pediatric chronic kidney disease patients
Stella Stabouli1, Eleni Papadimitriou2, Nikoleta Printza2
1Pediatric Nephrology Unit, 1st Pediatric Department, Hippokration Hospital, Aristotle University of Thessaloniki, 49 Konstantinoupoleos Street, 54642, Thessaloniki, Greece. sstaboul@auth.gr.
Insights
Children with chronic kidney disease (CKD) have a high prevalence of sleep disorders, significantly impacting their health-related quality of life (HRQOL). Early identification and management of these sleep issues are crucial for improving patient outcomes.
Area of Science:
- Pediatric Nephrology
- Sleep Medicine
- Quality of Life Research
Background:
- Sleep disorders are common in childhood, affecting 25-43% of the pediatric population.
- Chronic kidney disease (CKD) may exacerbate sleep disturbances in children.
- Health-related quality of life (HRQOL) is a critical outcome measure in pediatric chronic conditions.
Purpose of the Study:
- To determine the prevalence of sleep disorders in children with CKD.
- To explore associations between sleep disorders and CKD-related factors.
- To assess the impact of sleep disorders on HRQOL in pediatric CKD patients.
Main Methods:
- Systematic literature search of PubMed, Embase, and Cochrane Library Databases.
- Inclusion of seven relevant studies focusing on sleep disorders in children with CKD.
- Assessment of sleep disturbances primarily through questionnaires, with one study using polysomnography.
Main Results:
- All reviewed studies reported an increased prevalence of sleep disorders in children with CKD.
- Prevalence of sleep disorders ranged from 32-85% depending on CKD status (dialysis, transplant, non-dialysis).
- Restless legs syndrome was the most common disorder (10-35%); sleep disorders were linked to reduced HRQOL.
Conclusions:
- Children with CKD exhibit a significantly higher prevalence of sleep disorders.
- Sleep disturbances are associated with poorer HRQOL in this vulnerable pediatric population.
- Further research and clinical attention to sleep issues in pediatric CKD are warranted.
Abstract:
The prevalence of sleep disorders during childhood has been estimated to range from 25 to 43 %. The aim of this review is to determine the prevalence of sleep disorders and possible associations with chronic kidney disease (CKD)-related factors and health-related quality of life (HRQOL) in children with CKD. An electronic systematic literature search for sleep disorders in children with CKD in Pubmed, Embase and the Cochrane Library Databases identified seven relevant articles for review, all of which reported an increased prevalence of sleep disorders in children with CKD. Five studies included children with CKD undergoing dialysis, and two studies included only non-dialysis patients. In all studies the presence of sleep disturbances was assessed by questionnaires; only one study compared the results of a validated questionnaire with laboratory-based polysomnography. The prevalence of any sleep disorder ranged from 77 to 85 % in dialysis patients, to 32-50 % in transplanted patients and 40-50 % in non-dialysis patients. The most commonly studied disorder was restless legs syndrome, which presented at a prevalence of 10-35 %. Three studies showed significant associations between presence of sleep disorders and HRQOL. We found consistent evidence of an increased prevalence of sleep disturbances in children with CKD, and these seemed to play a critical role in HRQOL.
More Related Videos
Related Concept Videos
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease IV: Nursing Management
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease I: Introduction
Pharmacokinetics in Pediatric Patients: Drug Excretion
Restless Leg Syndrome and Night Terrors
The exact cause of RLS is not fully understood, but it is believed to involve dopamine, a neurotransmitter that helps regulate muscle movement. Imbalances in dopamine levels...

